Diarrhea in young children: clinical picture, diagnosis, principles of therapy
Journal Title: Здоров`я дитини - Year 2018, Vol 13, Issue 0
Abstract
Many diseases in infants and young children are accompanied by the development of diarrheal syndrome. As a result, there are organic lesions and functional disorders in the intestine. It is well known fact that 1.4 billion children under 5 years in the world suffer from acute diarrhea, and 123 million of them are forced to seek medical help urgently, 9 million require inpatient care, and 1.8 million children die from dehydration. In this connection, the choice of therapeutic regimen remains urgent. Medications that slow intestinal motility (loperamide) are contraindicated in acute diarrhea in children, since the risk of side effects including ileus, drowsiness, nausea (mortality to 1 %) is high. Probiotics are living microbial drugs commonly used to prevent acute diarrhea. A large number of researches have been conducted, and results of meta-analyzes have been published that have revealed the effect of Escherichia coli strain Nissle 1917 (Mutaflor) in reducing the duration of diarrhea in children with acute gastroenteritis. Escherichia coli strain Nissle 1917 is one of the three bacteria in the world, which is better characterized at the molecular-biological level, the most investigated non-pathogenic and genetically stable strain in the world with 100-year history, having a genetic map, the genome of which is completely sequenced, genetic loci are deterministic. The product is included into the German Collection of Microorganisms and Cell Cultures (DSMZ). The purpose of our study was to improve the therapeutic approaches to the correction of diarrheal syndrome using Escherichia coli strain Nissle 1917 (Mutaflor) in the main treatment regimens. Seventy four children were examined and divided into two groups: the first group — children with diarrheal syndrome, who additionally received Mutaflor from the first day, the second group — children with diarrheal syndrome, who received traditional therapy. As a result of the study, the data were obtained proving the effectiveness of Escherichia coli strain Nissle 1917 (Mutaflor) in the treatment of diarrhea in young children, its beneficial effect not only on intestinal microflora and normalization of intestinal kinetics, but also on faster improvement of clinical symptoms, which allows recommending it to children from the first months of life.
Authors and Affiliations
O. Yu. Beloysova, K. V. Savytska, N. V. Pavlenko, I. G. Solodovnichenko, A. M. Kaafarani, A. Yu. Volianskyi
Keywords
Related Articles
- EP ID EP292300
- DOI 10.22141/2224-0551.13.0.2018.13118
- Views 85
- Downloads 0
Experience with the use of Stimol® in Acute Pyelonephritis in Children
The results of the clinical use of Stimol® in the comprehensive treatment of acute pyelonephritis in 58 children. It is established that the inclusion of metabolism corrector Stimol® in complex of medical treatment of pa...
Opportunities and prospects in the diagnosis of functional intestinal pathology
Irritable bowel syndrome (IBS) is the most commonly diagnosed gastrointestinal condition in the 21st century and also the most common cause for referral to gastroenterology clinics. Various mechanisms and theories have b...
Characteristic of Local Humoral Factors of Nonspecific Resistance in Children with Recurrent Respiratory Infections
In this paper we investigated the content of defensins-β1–3, lactoferrin, lysozyme, sIgA A in oropharyngeal secretion in children with recurrent respiratory infections (RRI), with RRI and chronic compensated tonsillitis...
Autoinflammatory Syndromes in the Practice of Pediatrician
This review article provides information, characterization, identification and classification of diseases that have been attributed to a separate nosological group and called autoinflammatory diseases or syndromes (ABC)....
Pressing Issues of Rational Antibiotic Therapy for Inflammatory Diseases of the Lower Respiratory Tract in Pediatric Practice
Over the past 30 years, high incidence of acute lower respiratory tract infections of bacterial origin, primarily pneumonia and bronchitis, treatment of which under the spread of antibiotic resistance is often a difficul...